180 related articles for article (PubMed ID: 16172844)
1. Invasive candidiasis: comparison of management choices by infectious disease and critical care specialists.
Eggimann P; Calandra T; Fluckiger U; Bille J; Garbino J; Glauser MP; Marchetti O; Ruef C; Täuber M; Pittet D;
Intensive Care Med; 2005 Nov; 31(11):1514-21. PubMed ID: 16172844
[TBL] [Abstract][Full Text] [Related]
2. EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodríguez A;
Rev Esp Quimioter; 2014 Sep; 27(3):196-212. PubMed ID: 25229375
[TBL] [Abstract][Full Text] [Related]
3. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
[TBL] [Abstract][Full Text] [Related]
4. Impact of a multifaceted educational intervention including serious games to improve the management of invasive candidiasis in critically ill patients.
Ferrer R; Zaragoza R; Llinares P; Maseda E; Rodríguez A; Quindós G;
Med Intensiva; 2017; 41(1):3-11. PubMed ID: 27645566
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
6. [Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey].
Alvarez-Lerma F; Nolla J; Palomar M; León MA
Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):83-8. PubMed ID: 12586031
[TBL] [Abstract][Full Text] [Related]
7. Épico Project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3):135-49. PubMed ID: 23727234
[TBL] [Abstract][Full Text] [Related]
8. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
9. Invasive Candida infections in children: the clinical characteristics and species distribution and antifungal susceptibility of Candida spp.
Belet N; Ciftçi E; Aysev D; Güriz H; Uysal Z; Taçyildiz N; Atasay B; Doğu F; Kendirli T; Kuloğlu Z; Ince E; Doğru U
Turk J Pediatr; 2011; 53(5):489-98. PubMed ID: 22272448
[TBL] [Abstract][Full Text] [Related]
10. Antifungal resistance: the clinical front.
Perfect JR
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):15-22. PubMed ID: 15682590
[TBL] [Abstract][Full Text] [Related]
11. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
12. Anidulafungin: a new echinocandin with a novel profile.
Vazquez JA
Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974
[TBL] [Abstract][Full Text] [Related]
13. [Épico project: Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Grupo Proyecto Épico].
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3 Suppl 1):135-49. PubMed ID: 23764554
[TBL] [Abstract][Full Text] [Related]
14. [Is the use of antifungal management advisable in critical patients with positive isolation of Candida spp. from intraabdominal clinical samples?].
Zaragoza R; Pemán J; Salavert M
Rev Iberoam Micol; 2008 Dec; 25(4):203-7. PubMed ID: 19071886
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
[TBL] [Abstract][Full Text] [Related]
17. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
18. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
Shorr AF; Wu C; Kothari S
J Antimicrob Chemother; 2011 Feb; 66(2):375-80. PubMed ID: 21147825
[TBL] [Abstract][Full Text] [Related]
19. Invasive candidosis: contrasting the perceptions of infectious disease physicians and intensive care physicians.
Schultz V; Colombo AL; Pasqualotto AC
Rev Soc Bras Med Trop; 2013; 46(4):466-71. PubMed ID: 23904078
[TBL] [Abstract][Full Text] [Related]
20. ÉPICO project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Esp Anestesiol Reanim; 2013; 60(7):e1-e18. PubMed ID: 23911095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
